Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05346848
Title A Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer (DARIUS)
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonie
Indications

prostate cancer

Therapies

Darolutamide

Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Sainte Catherine, Institut du Cancer Avignon-Provence Avignon 84918 France Details
CHRU Besançon Besançon 25030 France Details
Institut Bergonie Bordeaux 33076 France Details
CHRU Brest - Hôpital Morvan Brest 29200 France Details
Assitance Publique des Hôpitaux de Marseille - CHU La Timone Marseille 13385 France Details
Hôpital de la Pitié Salpétrière Paris 75651 France Details
CHP Saint-Grégoire Saint-Grégoire 35760 France Details
Institut de Cancérologie de l'Ouest - Site René Gauducheau Saint-Herblain 44805 France Details
IUCT Oncopôle Toulouse 31059 France Details
Clinique Pasteur Toulouse 31076 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field